Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
March
30
RNA biomarkers may help confirm heart disease, study finds
Week in Review: FDA outlines EUA transition | Genetic test fraud and kickbacks | A CEO change in proteomics
With COVID-19 public emergency declaration ending, FDA outlines transition plan for tests with EUAs
Genetic variations in study increased H. pylori-related stomach cancer risk
C2N Diagnostics announces study confirming accuracy of test for Alzheimer’s diagnosis
Ad Astra Diagnostics files FDA 510(k) application for point-of-care hematology analyzer
Page 1 of 1